Osteoporosis
📧 Sign up to get email alerts when something new happens for Osteoporosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-10-14Clinical Trial Update: Changes in Biochemical Markers of Bone Turnover (Serum CTX and PlNP) After Initiation of a "Drug Holiday" From Bisphosphonates [NA]
This clinical trial update describes changes in biochemical markers of bone turnover (serum CTX and P1NP) after initiating a drug holiday fr…
-
FDA label_change · 2015-10-08FDA Approved: ZOLEDRONIC ACID — Supplemental Application (Sagent Pharmaceuticals)
FDA supplemental application for Zoledronic Acid submitted by Sagent Pharmaceuticals to modify the drug's labeling.
-
CLINICAL_TRIALS trial_result · 2015-10-08Clinical Trial Update: Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis [Phase 4]
A Phase 4 clinical trial comparing teriparatide and denosumab for bone health in postmenopausal osteoporosis completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2015-10-06Clinical Trial Update: Effects of Hesperidin on Bone Biomarkers in Postmenopausal Women [Phase 2]
A Phase 2 clinical trial update from Nestlé SPN reports on the effects of hesperidin on bone biomarkers in postmenopausal women with osteope…
-
CLINICAL_TRIALS research · 2015-10-05Clinical Trial Update: Follow-up of Bone Quality in Long-Term Bone Marrow Transplant Survivors
A completed clinical trial follow-up evaluating bone quality and osteoporosis-related outcomes in long-term bone marrow transplant survivors…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-10-05Clinical Trial Update: Does Gender Play a Role in Bone-mineral Density Measurement Precision?
A completed clinical trial examined whether gender influences the precision of bone mineral density measurements in individuals with osteopo…
-
CLINICAL_TRIALS trial_result · 2015-10-05Clinical Trial Update: Bone Microarchitecture in Women With and Without Fracture
This clinical trial update reports the completion of a study evaluating bone microarchitecture in women with and without fracture, sponsored…
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: Study of AK156 in Primary Osteoporosis Patients [Phase 3]
A Phase 3 clinical trial evaluating AK156 for primary osteoporosis has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-29Clinical Trial Update: Teriparatide Treatment in Patients With Inherited Osteoporosis [Phase 4]
This document reports the completion of a Phase 4 clinical trial evaluating teriparatide for inherited osteoporosis.
-
CLINICAL_TRIALS trial_result · 2015-09-29Clinical Trial Update: Bisphosphonates Effects On Alveolar Bone Among Osteoporotic Women
A completed clinical trial evaluating the effects of bisphosphonates on alveolar bone in osteoporotic women.
-
CLINICAL_TRIALS trial_result · 2015-09-28Clinical Trial Update: Wellnara Post-marketing Surveillance in Japan
Bayer's Wellnara post-marketing surveillance study in Japan on osteoporosis (postmenopausal) has completed, collecting real-world safety and…
-
CLINICAL_TRIALS trial_result · 2015-09-25Clinical Trial Update: Soy, Bone and Health in College Females [NA]
A completed clinical trial evaluating the effects of soy on osteoporosis and obesity in college-aged women.
-
FDA approval · 2015-09-23FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for alendronate sodium by Hikma Pharmaceuticals USA Inc., adding regulatory approval status for this…
-
FDA approval · 2015-09-21FDA Approved: ZOLEDRONIC ACID — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA approved a supplemental application for zoledronic acid from Dr. Reddy's Laboratories Limited.
-
CLINICAL_TRIALS withdrawal · 2015-09-17Clinical Trial Update: Teriparatide for Fracture Repair in Humans [Phase 3]
A Phase 3 trial evaluating teriparatide for fracture repair in patients with osteoporosis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-09-14Clinical Trial Update: Maternal and Infant Vitamin Status During the First Nine Months of Infant Life
This is a completed clinical trial update examining maternal and infant vitamin status during the first nine months of life.
-
CLINICAL_TRIALS trial_result · 2015-09-09Clinical Trial Update: Switching From Oral Bisphosphonates to Bazedoxifene to Evaluate Effects on Bone Mineral Density in Postmenopausal Women [Phase 4]
Phase 4 trial evaluating switching from oral bisphosphonates to bazedoxifene and its effects on bone mineral density in postmenopausal women…
-
CLINICAL_TRIALS trial_result · 2015-09-07Clinical Trial Update: Bone Loss After Laparoscopic Roux-en-Y Gastric Bypass
A completed clinical trial update examining bone loss and changes in bone density after laparoscopic Roux-en-Y gastric bypass.
-
FDA approval · 2015-09-02FDA Approved: IBANDRONATE SODIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for ibandronate sodium submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2015-09-02FDA Approved: IBANDRONATE SODIUM — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for ibandronate sodium submitted by Mylan Institutional LLC (ANDA 202671), indicating approved chang…
-
CLINICAL_TRIALS trial_result · 2015-09-01Clinical Trial Update: Kefir on Bone Mineral Density and Bone Metabolism in Osteoporotic Patients [NA]
Completed clinical trial evaluating kefir's effect on bone mineral density and bone metabolism in patients with osteoporosis.
-
FDA approval · 2015-08-28FDA Approved: RALOXIFENE HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
The FDA approved Aurobindo Pharma Limited's original application for raloxifene hydrochloride as a generic medication for postmenopausal ost…
-
CLINICAL_TRIALS withdrawal · 2015-08-27Clinical Trial Update: Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Alendronate (MK-0822-050) [Phase 3]
The Phase 3 trial MK-0822-050 evaluating odanacatib in postmenopausal osteoporosis previously treated with alendronate has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: Parathyroid Hormone (PTH) With Alendronate for Osteoporosis [Phase 2]
Phase 2 clinical trial update evaluating the combination of teriparatide (parathyroid hormone) with alendronate for osteoporosis; the study …
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: A Study to Assess the Effects of a Light Breakfast on the Safety, Tolerability, and Pharmacokinetics of Odanacatib (MK0822) [Phase 1]
A completed Phase 1 study evaluated the effects of a light breakfast on the safety, tolerability, and pharmacokinetics of odanacatib (MK0822…